Temporal, Location- and Symptom-Specific Likelihood of Patient-Reported Sensory Symptoms Related to Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in Patients Receiving Oxaliplatin for Three Months
- Citation:
- Cancers (Basel) vol 14 (5) 1212
- Year:
- 2022
- Type:
- Manuscript
- Funding:
- Foundation
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-internal-user
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- Yes
- Biospecimen:
- No
- SDC:
- Yes
- Book Volume:
- 11
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Alliance for Clinical Trials in Oncology Foundation, Alliance Daniel J. Sargent, PhD Memorial Fellowship in Innovated Clinical Trial Design and Methods
- Corr. Author:
- Authors:
- David Zahrieh Daniel Satele Ellen M. Lavoie Smith Charles L. Loprinzi Jennifer Le-Rademacher
- Networks:
- Study
- Alliance-A152116
- Multiple Studies, or Legacy Studies in Alliance Study:
- NCCTG-N08CB, MC11C4
- Phases:
- N/A, 3, N/A
- Keywords: